Review identifies common food additives in ultra-processed foods—particularly emulsifiers like carrageenan and polysorbate 80 ...

H.C. Wainwright analyst Andres Maldonado lowered the firm’s price target on Mural Oncology (MURA) to $6 from $18 and keeps a Buy rating on the ...

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

Mural Oncology ends nemvaleukin development for ovarian cancer after ARTISTRY-7 trial misses survival goals. Phase 2 trials ...

Alternative methods for tracheal intubation such as using a flexible intubation scope, video laryngoscope, and supraglottic ...

An Ohio State University study finds that many people lack crucial information about human papillomavirus transmission and ...

Cold endoscopic mucosal resection (EMR) showed a superior safety profile over traditional hot EMR for large nonpedunculated colorectal polyps measuring ≥ 20 mm, with significantly lower risks of ...

Painful inflammation that takes months or up to a year to heal—this can be seen in the mouth after using white snus.

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

Annie Antar, MD, PhD, spoke about how long viral clearance could be an indicator of long COVID, but more research would need to be done to confirm this.

Nemvaleukin alfa with pembrolizumab missed the overall survival primary end point in ARTISTRY-7 for platinum-resistant ...

Raymond James downgraded Mural Oncology (MURA) to Outperform from Strong Buy with a price target of $6, down from $18, after the company ...